These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9593171)

  • 1. Susceptibilities of neonatal respiratory isolates of Ureaplasma urealyticum to antimicrobial agents.
    Matlow A; Th'ng C; Kovach D; Quinn P; Dunn M; Wang E
    Antimicrob Agents Chemother; 1998 May; 42(5):1290-2. PubMed ID: 9593171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic susceptibilities and therapeutic options for Ureaplasma urealyticum infections in neonates.
    Waites KB; Crouse DT; Cassell GH
    Pediatr Infect Dis J; 1992 Jan; 11(1):23-9. PubMed ID: 1549404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Etest for susceptibility testing of Mycoplasma hominis and Ureaplasma urealyticum.
    Dósa E; Nagy E; Falk W; Szöke I; Ballies U
    J Antimicrob Chemother; 1999 Apr; 43(4):575-8. PubMed ID: 10350390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin.
    Samra Z; Rosenberg S; Dan M
    J Chemother; 2011 Apr; 23(2):77-9. PubMed ID: 21571622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of erythromycin on respiratory colonization of Ureaplasma urealyticum and the development of chronic lung disease in extremely low birth weight infants.
    Bowman ED; Dharmalingam A; Fan WQ; Brown F; Garland SM
    Pediatr Infect Dis J; 1998 Jul; 17(7):615-20. PubMed ID: 9686728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ureaplasma urealyticum and Ureaplasma parvum in etiology of urogenital mixt-infections].
    Naumkina EV; Rudakov NV; Pakhalkova EV; Temnikova NV; Reshetnikova TA; Berezkina GV
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (3):93-5. PubMed ID: 16830600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic Susceptibility and Sequence Type Distribution of Ureaplasma Species Isolated from Genital Samples in Switzerland.
    Schneider SC; Tinguely R; Droz S; Hilty M; Donà V; Bodmer T; Endimiani A
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6026-31. PubMed ID: 26195516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence and antimicrobial susceptibility of Ureaplasma parvum (Ureaplasma urealyticum biovar 1) and Ureaplasma urealyticum (Ureaplasma urealyticum biovar 2) from patients with adverse pregnancy outcomes and normal pregnant women.
    Martínez MA; Ovalle A; Santa-Cruz A; Barrera B; Vidal R; Aguirre R
    Scand J Infect Dis; 2001; 33(8):604-10. PubMed ID: 11525356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in female outpatients, 2009-2013.
    Wang QY; Li RH; Zheng LQ; Shang XH
    J Microbiol Immunol Infect; 2016 Jun; 49(3):359-62. PubMed ID: 25081985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of erythromycin for treatment of incipient chronic lung disease in preterm infants colonised with Ureaplasma urealyticum.
    Bührer C; Hoehn T; Hentschel J
    Drugs; 2001; 61(13):1893-9. PubMed ID: 11708762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in genital samples collected over 6 years at a Serbian university hospital.
    Skiljevic D; Mirkov D; Vukicevic J
    Indian J Dermatol Venereol Leprol; 2016; 82(1):37-41. PubMed ID: 26728808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ureaplasma urealyticum meningitis in an adult patient.
    Geissdörfer W; Sandner G; John S; Gessner A; Schoerner C; Schröppel K
    J Clin Microbiol; 2008 Mar; 46(3):1141-3. PubMed ID: 18174297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appropriate antibiotic therapy improves Ureaplasma sepsis outcome in the neonatal mouse.
    Weisman LE; Leeming AH; Kong L
    Pediatr Res; 2012 Nov; 72(5):502-6. PubMed ID: 22907617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of clinical symptoms in female patients with acute urethral syndrome caused by Ureaplasma urealyticum treated with azithromycin or doxycycline.
    Skerk V; Schönwald S; Strapac Z; Beus A; Francetić I; Krhen I; Lesko V; Vukovic J
    J Chemother; 2000 Dec; 12(6):533-5. PubMed ID: 11154040
    [No Abstract]   [Full Text] [Related]  

  • 15. [Voice on the treatment of ureaplasmas infections].
    Biernat-Sudolska M; Rojek-Zakrzewska D; Drzewiecki A
    Przegl Epidemiol; 2009; 63(1):85-8. PubMed ID: 19522233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of mixed infection of Ureaplasma Urealyticum and Mycoplasma Hominis to seven antimicrobial agents and comparison with that of Ureaplasma Urealyticum infection.
    Huang C; Liu Z; Lin N; Tu Y; Li J; Zhang D
    J Huazhong Univ Sci Technolog Med Sci; 2003; 23(2):203-5. PubMed ID: 12973952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in-vitro activity of levofloxacin, other fluoroquinolones, doxycycline and erythromycin against Ureaplasma urealyticum and Mycoplasma hominis.
    Ullmann U; Schubert S; Krausse R
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():33-6. PubMed ID: 10404335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug sensitivity of Ureaplasma urealyticum, persisting in patients with chronic inflammatory diseases of the urogenital tract].
    Gamova NA
    Zh Mikrobiol Epidemiol Immunobiol; 2003; (4):81-5. PubMed ID: 12966887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in biofilm development and antibiotic susceptibility among clinical Ureaplasma urealyticum and Ureaplasma parvum isolates.
    García-Castillo M; Morosini MI; Gálvez M; Baquero F; del Campo R; Meseguer MA
    J Antimicrob Chemother; 2008 Nov; 62(5):1027-30. PubMed ID: 18753188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative randomized pilot study of azithromycin and doxycycline efficacy and tolerability in the treatment of prostate infection caused by Ureaplasma urealyticum.
    Skerk V; Mareković I; Markovinović L; Begovac J; Skerk V; Barsić N; Majdak-Gluhinić V
    Chemotherapy; 2006; 52(1):9-11. PubMed ID: 16340190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.